We are live on ! Find out more
TTNP

Titan Pharmaceuticals
TTNP

Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

15 hedge funds and large institutions have $9.41K invested in Titan Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.53% less ownership

Funds ownership: 1.85% → 0.32% (-1.5%)

6% less funds holding

Funds holding: 16 → 15 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

89% less capital invested

Capital invested by funds: $88.5K → $9.41K (-$79.1K)

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
+$20

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$58.3K
2
UBS Group
UBS Group
Switzerland
-$8.57K
3
TRCT
Tower Research Capital (TRC)
New York
-$3.92K
4
Morgan Stanley
Morgan Stanley
New York
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$8.69K -$8.57K -2,106 -44%
MA
2
MCF Advisors
Kentucky
$538 – – –
Bank of America
3
Bank of America
North Carolina
$55 – – –
Osaic Holdings
4
Osaic Holdings
Arizona
$47 +$20 +5 +50%
Group One Trading
5
Group One Trading
Illinois
$39 – – –
Morgan Stanley
6
Morgan Stanley
New York
$10 -$4 -1 -25%
GWSA
7
Global Wealth Strategies & Associates
Colorado
$7 – – –
CSC
8
Caldwell Sutter Capital
California
$3 – – –
CIA
9
Cape Investment Advisory
Georgia
$3 – – –
DJSG
10
D.J. St. Germain
Massachusetts
$3 – – –
NRG
11
Nemes Rush Group
Michigan
$3 – – –
RA
12
Ransom Advisory
Rhode Island
$3 – – –
Wells Fargo
13
Wells Fargo
California
$3 – – –
WIM
14
Westside Investment Management
California
$3 – – –
SS
15
SBI Securities
Japan
$3 +$4 +1 New
Renaissance Technologies
16
Renaissance Technologies
New York
– -$58.3K -11,066 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$3.92K -743 Closed

TTNP Hedge Fund Activity: Q4 2024 in Review

15 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q4 2024, worth a combined $9.41K — down 89% from $88.5K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TTNP and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Osaic Holdings, adding an estimated $20. The largest seller was Renaissance Technologies, exiting entirely with an estimated $58.3K sold.

  • 15 institutional investors held Titan Pharmaceuticals (TTNP) as of Q4 2024, down from 16 in Q3 2024.
  • Funds reported $9.41K of Titan Pharmaceuticals stock for Q4 2024, down 89% quarter-over-quarter.
  • 1 fund opened new Titan Pharmaceuticals positions in Q4 2024 and 2 closed out, a net change of -1 holder.
  • The largest Titan Pharmaceuticals buyer in Q4 2024 was Osaic Holdings, an estimated $20 added.
  • The largest Titan Pharmaceuticals seller in Q4 2024 was Renaissance Technologies, an estimated $58.3K sold.

Based on aggregated 13F filings for Q4 2024.